Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2022
09 January 2023 - 8:00AM
Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial
Biology Company®, today announced preliminary unaudited revenue for
the fourth quarter and full year ended December 31, 2022.
Akoya reported the following preliminary financial results for
the fourth quarter and full year 2022, which remain subject to
quarter end closing adjustments:
- Revenue for the fourth quarter of
2022 is expected to be between $20.7 million and $21.2 million, as
compared to $16.2 million for the corresponding quarter of last
year
- For the fiscal year of 2022, revenue
is expected to be between $74.3 million and $74.8 million, as
compared to $54.9 million for fiscal year 2021
“The fourth quarter of 2022 was another record quarter for
Akoya, demonstrating our continued business momentum and commercial
execution,” said Brian McKelligon, Chief Executive Officer. “In
2022, we delivered strong financial performance and saw growing
adoption of our spatial biology platforms across the discovery,
translational, and clinical markets.”
A link to a webcast replay of Akoya’s 2nd annual Spatial Day,
which took place virtually on December 15, 2022, can be found
below:
Akoya Biosciences Spatial Day 2022 | Akoya
The financial results in this press release reflect expectations
based on currently available information. The company has yet to
complete its quarter end closing and actual results are therefore
subject to change.
Use of forward-looking statements
This press release contains forward-looking statements that are
based on management’s beliefs and assumptions and on information
currently available to management. All statements contained in this
release other than statements of historical fact are
forward-looking statements, including statements regarding our
fourth quarter 2022 revenue outlook.
In some cases, you can identify forward-looking statements by
the words “may,” “will,” “could,” “would,” “should,” “expect,”
“intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,”
“project,” “potential,” “continue,” “ongoing” or the negative of
these terms or other comparable terminology, although not all
forward-looking statements contain these words. These statements
involve risks, uncertainties and other factors that may cause
actual results, levels of activity, performance, or achievements to
be materially different from the information expressed or implied
by these forward-looking statements. These risks, uncertainties and
other factors are described under the captions "Risk Factors," and
"Management's Discussion and Analysis of Financial Condition and
Results of Operations" and elsewhere in the documents we file with
the Securities and Exchange Commission from time to time. We
caution you that forward-looking statements are based on a
combination of facts and factors currently known by us and our
projections of the future, about which we cannot be certain. As a
result, the forward-looking statements may not prove to be
accurate. The forward-looking statements in this press release
represent our views as of the date hereof. We undertake no
obligation to update any forward-looking statements for any reason,
except as required by law.
About Akoya BiosciencesAs The Spatial Biology
Company®, Akoya Biosciences’ mission is to bring context to the
world of biology and human health through the power of spatial
phenotyping. The company offers comprehensive single-cell imaging
solutions that allow researchers to phenotype cells with spatial
context and visualize how they organize and interact to influence
disease progression and response to therapy. Akoya offers a full
continuum of spatial phenotyping solutions to serve the diverse
needs of researchers across discovery, translational and clinical
research: PhenoCode™ Panels and PhenoCycler®, PhenoImager® Fusion
and PhenoImager HT Instruments. To learn more about Akoya,
visit www.akoyabio.com.
Investor Contact:Priyam ShahSr. Director,
Investor RelationsAkoya Biosciences, Inc.investors@akoyabio.com
Media Contact:Christine Quern(617)
650-8497media@akoyabio.com
Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
From Apr 2023 to Apr 2024